Bioinformatics software company Qlucore has enhanced its financial position with a combination of a rights issue and a development loan from Swedish regional development fund ALMI
Cray has announced the creation of the Cray Europe, Middle East and Africa (EMEA) Research Lab, with the aim of fostering the development of deep technical collaborations with key customers and partners
With the addition of a novel metal-organic paddle-wheel structure from researchers in Spain, the Cambridge Structural Database has passed the milestone of 800,000 expert-curated experimental crystal structure entries
Bright Computing has significantly expanded its global network of channel partners, local resellers, local system integrators, as well as original equipment manufacturers
A collaboration has been announced between IronCAD and NCG CAM at Merrem Kunststoffen B.V. in the Netherlands
Participating teams in the Formula SAE and SAE Aero Design 2015 competitions had the opportunity to use Maplesoft's tools in their product designs, thanks to the company's sponsorship of the SAE Collegiate Design Competitions.
Accelerated Technology Laboratories (ATL) has been selected by Food Safety ARC to be its partner for laboratory information management systems (LIMS) based on its LIMS and automation expertise in the food and drink market
Qlucore, a developer of bioinformatics software, has announced a three year license contract with Actelion, one of Europes leading biopharmaceutical companies
According to the latest edition of the local Top50 list of the most powerful supercomputers in Russia and CIS region, RSC has increased its share by 80%
GENALICE, the biomedical big data solutions company, and Personalised medicine & biotechnology company Macrogen have jointly announced that Macrogen has chosen GENALICE MAP to reinforce its big data processing and analysis capacity for large-scale genome analysis and clinical sequencing services
The automotive sector is undergoing a period of rapid and disruptive transformation from both a business and technical standpoint.
Estimates suggest that the global laboratory informatics market, valued at $2.6 billion in 2019, will witness CAGR of 7.5 per cent over the next five years, reaching $3.8 billion in 2024[1].
Modern drug discovery and development workflows incorporate a growing range of automated, high-throughput technologies that can generate data on a truly impressive scale.
‘This will be the life sciences century … because of personalised medicine, information technology, and knowledge on biological systems,’ said Fred Hassan, a partner of Warburg Pincus and former CEO of Schering-Plough.
With data rates increasing and more complex challenges arising in life sciences, Panasas’ Jim Donovan and Dale Brantly discuss the benefits of using HPC for these workloads
As the complexity of both HPC hardware and the challenges that scientists are trying to solve using HPC systems increases, ensuring a system is utilised efficiently is necessary to deliver a computing service with value for money and a high research output.
Architectural specialisation is one option to continue to improve performance beyond the limits imposed by the slow down in Moore’s Law.
As not only the HPC industry but the larger computing ecosystem tries to overcome the slowdown and eventual end of transistor scaling described by Moore’s Law, scientists and researchers are implementing programmes that will define the technologies and new materials needed to supplement, or repla
